Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Chartwell Pharmaceuticals Amityville, LLC
FDA Inspection
•Chartwell Pharmaceuticals Amityville, LLC•December 3, 2009

Chartwell Pharmaceuticals Amityville, LLC – FDA Inspection, Dec 3, 2009

Record Details

This FDA Inspection record concerns Chartwell Pharmaceuticals Amityville, LLC, with an inspection on December 3, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Chartwell Pharmaceuticals Amityville, LLC
Inspection Date
December 3, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · dc128a88-c7a3-4562-a56c-a845d3d286a4

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
629631
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

9
  1. 21 CFR 211.188Prepared for each batch, include complete information
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.160(b)(3)Drug products-sampling procedures/specifications
  5. 21 CFR 211.160(b)(1)Incoming lots - conformance to written specs-
  6. 21 CFR 211.160(b)Scientifically sound laboratory controls
  7. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  8. 21 CFR 211.165(a)Testing and release for distribution
  9. 21 CFR 211.165(e)Test methods

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Chartwell Pharmaceuticals Amityville, LLC

13
DateClassificationOfficeProject area
December 21, 2022VAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
February 13, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 20, 2017Not classifiedNew York District Office
May 5, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 15, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 13 other inspections on the company page
Other documents for Chartwell Pharmaceuticals Amityville, LLC
  • FDA Inspection 1193806 - 2022-12-21
  • FDA Inspection 1079804 - 2019-02-13
  • FDA Inspection 1020105 - 2017-07-20
  • FDA Inspection 1011507 - 2017-05-05
  • FDA Inspection 980564 - 2016-07-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chartwell Pharmaceuticals Amityville, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.